Seguir
Adnan Arnaout
Adnan Arnaout
Prevail Therapeutics & City University of New York
E-mail confirmado em prevailtherapeutics.com - Página inicial
Título
Citado por
Citado por
Ano
Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity: miniperspective
R Alshehri, AM Ilyas, A Hasan, A Arnaout, F Ahmed, A Memic
Journal of medicinal chemistry 59 (18), 8149-8167, 2016
3812016
Toward a neurospheroid niche model: Optimizing embedded 3D bioprinting for fabrication of neurospheroid brain-like co-culture constructs
YCE Li, YA Jodat, R Samanipour, G Zorzi, K Zhu, M Hirano, K Chang, ...
Biofabrication 13 (1), 015014, 2020
432020
hiPSC-derived 3D bioprinted skeletal muscle tissue implants regenerate skeletal muscle following volumetric muscle loss
YA Jodat, T Zhang, Z Al Tanoury, T Kamperman, K Shi, Y Huang, ...
42021
Microglial-targeted Gene Therapy: Developing a Disease Modifying Treatment for ALSP Associated with CSF1R Mutations (ALSP-CSF1R)(P11-4.012)
N Masoudi, J Willen, C Daniels, BA Jenkins, EC Furber, M Kothiya, ...
Neurology 102 (17_supplement_1), 3061, 2024
2024
A Tale of Two Capsids: TREM2 gene therapy reduces pathological amyloid-beta in 5xFAD mouse model
J Willen, B Shykind, S Kalan, J Hendricks, M Kothiya, L Wong, C Daniels, ...
HUMAN GENE THERAPY 33 (23-24), A30-A30, 2022
2022
Analytical comparison of AAV manufactured by triple-plasmid transfection/HEK293 and double-baculovirus infection/SF9 processes
M Ng, S Nelson, S Kakkar, A Arnaout, T Fenn, G Danniels, J Zhou, P Raut, ...
HUMAN GENE THERAPY 33 (23-24), A35-A35, 2022
2022
Novel Method for Measuring Infectious Titer of Adeno-Associated Virus Serotype 9 Using ddPCR
A Arnaout, J Haller
MOLECULAR THERAPY 30 (4), 364-364, 2022
2022
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–7